E/C tablets

M/R tablets

Crushable tablets

SF liquid

M/R granules see Episenta^®

On specialist advice

 Use in men and women of non-child bearing potential

 Use in women and girls of childbearing potential (all indications).

Contraindicated in women of childbearing potential unless part of the Pregnancy Prevention Programme. See MHRA guidance

MHRA Advice
Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history

Paediatrician initiation for patients with epilepsy aged up to and including 16 years of age unable to swallow tablets and who require a modified release formulation in whom other formulations are more expensive or not appropriate

Contraindicated in women of childbearing potential unless part of the Pregnancy Prevention Programme. See MHRA guidance

MHRA Advice
Care should be taken when switching between oral formulations. The need for continued supply of a particular manufacturer’s product should be based on clinical judgement and consultation with patient and/or carer, taking into account factors such as seizure frequency and treatment history